65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79724D0115
- Awardee
-
Revance Therapeutics, Inc. UEI HY78DQBTLLG3
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 49% complete
- IDV ceiling
- $225,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
This Federal Supply Schedule contract awards a $225,000 ceiling value to Revance Therapeutics, Inc. (UEI: HY78DQBTLLG3) for the provision of drugs, pharmaceuticals, and hematology-related products under General Services Administration (GSA) schedule 61-IB. The contract was awarded on May 15, 2024, with an ultimate completion date of May 14, 2029, representing a five-year term. As a multiple award Indefinite Delivery Vehicle with no set-aside designation, this contract allows the Department of Veterans Affairs, Veterans Integrated Service Network 12, to procure pharmaceutical products on an as-needed basis within the established ceiling. The pricing structure is subject to the Public Law 102-585 pricing update mechanism, which ensures that contract rates remain consistent with applicable pricing requirements throughout the contract period.
The contract falls within the Pharmaceuticals and Drugs Federal Supply Schedule, a general schedule vehicle that enables federal agencies to access pharmaceutical products and related supplies at pre-negotiated rates. Veterans Integrated Service Network 12 established this indefinite quantity procurement to support pharmaceutical supply requirements across its healthcare facilities and operations. The multiple award structure permits the Veterans Affairs system to source products from Revance Therapeutics alongside other qualified contractors on the same schedule, providing flexibility in procurement while maintaining competitive pricing mechanisms. Specific task orders or delivery orders issued under this Federal Supply Schedule contract will define individual procurement quantities, delivery schedules, and performance locations as requirements arise during the contract period.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79724D0115?
36F79724D0115 was awarded to Revance Therapeutics, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on May 15, 2024.
How much is contract 36F79724D0115 worth?
36F79724D0115's own ceiling is $225,000.
Who can order from contract 36F79724D0115?
36F79724D0115 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79724D0115 part of a contract vehicle?
Yes. 36F79724D0115 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79724D0115 competed?
The extent of competition for 36F79724D0115 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV